Efficacy and Safety of Haloperidol in the Prevention and Management of Delirium in Medical Inpatients: An Umbrella Review of Systematic Reviews
Open Access
- 18 June 2025
- journal article
- review article
- Published by SAGE Publications in Indian Journal of Psychological Medicine
- Vol. 48 (2) , 117-126
Abstract
Purpose of the review: Delirium occurs in up to 31% of general hospital patients in the medical, surgical, or critical care wards. Agitation is common during hyperactive delirium, which poses a risk to themselves, other patients, or staff. Evidence for using oral or parenteral haloperidol from randomized controlled trials and published systematic reviews shows divergent findings, ranging from good response to no difference compared to placebo, despite its popularity in routine clinical use. We decided to perform an umbrella review of systematic reviews on the efficacy and safety of haloperidol in delirium. Collection and Analysis of Data: This protocol was registered with PROSPERO CRD42024502020. We searched PubMed, Ovid MEDLINE, and PsychINFO for systematic reviews with meta-analyses published in English only over the previous 20 years. These were searched under title, abstract, and Medical Subject Headings (MeSH) terms as applicable. We used Assessing the Methodological Quality of Systematic Reviews 2 to assess the quality of the articles. Ten systematic reviews were finally selected for review that focused on either preventing or treating delirium. The summary of results did not find that haloperidol is effective in preventing or treating delirium, though all included reviews found it a safe drug to use. Heterogeneity from I 2 statistics varied from a moderate to a high degree and may be attributable to population, outcomes, and setting variations. Conclusions: The authors conclude that there is limited evidence for haloperidol in preventing or treating delirium. Future studies must not aim to assess the resolution of delirium; instead, they must modify outcome measures, to mainly behavioral and psychiatric symptoms such as agitation, hallucinations, and persecutory delusions in delirium.Keywords
This publication has 37 references indexed in Scilit:
- Hyperactive Delirium with Severe AgitationEmergency Medicine Clinics of North America, 2023
- Can haloperidol prophylaxis reduce the incidence of delirium in critically ill patients in intensive care units? A systematic review and meta-analysisHeart & Lung, 2020
- Efficacy and safety of haloperidol for delirium prevention in adult patients: An updated meta-analysis with trial sequential analysis of randomized controlled trialsJournal of Clinical Anesthesia, 2020
- Assessment of Instruments for Measurement of Delirium SeverityJAMA Internal Medicine, 2019
- Prevalence and risk factors related to haloperidol use for delirium in adult intensive care patients: the multinational AID-ICU inception cohort studyIntensive Care Medicine, 2018
- Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of DeliriumJAMA, 2018
- Efficacy and safety of haloperidol for in-hospital delirium prevention and treatment: A systematic review of current evidenceEuropean Journal of Internal Medicine, 2016
- Olanzapine vs haloperidol: treating delirium in a critical care settingIntensive Care Medicine, 2003
- Usage of haloperidol for delirium in cancer patientsSupportive Care in Cancer, 1996
- A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neurolepticsPsychopharmacology, 1975